More Power in Less Space: Redodo 12V 165Ah Bluetooth Lithium Battery Drops to $309 During Prime Day Sale
As part of its highly anticipated Prime Day Sale, Redodo, a leading innovator in lithium iron phosphate (LiFePO4) energy solutions, is offering the best Prime Day deals at the official store, and its latest 12V 165Ah Bluetooth Lithium Battery now available at a record-low price of $309 for a limited time only.
Born for small RVs, off-grid cabins, and space-limited setups, this compact Group 31 battery is built to deliver maximum capacity without taking up extra room. With 2112Wh of energy and 2112W of high output power, it can run essential appliances from lights to refrigerators with ease. It's the top choice for RV travelers and off-grid enthusiasts who need more capacity and long-lasting performance in compact RVs and limited space.
What Makes Redodo 12V 165Ah Battery Stand Out?65% More Capacity in a Group 31 Standard Size
Group 31 batteries are standard in RVs and boats—but most are old-school lead-acid with limited capacity and tons of weight. Redodo's 165Ah unit, using LiFePO4 chemistry, delivers 65% more capacity in the same footprint. That means over 18 extra hours powering a 50W fridge compared to a 100Ah lead-acid, all while slashing weight—this one weighs just 33 lbs, about 82% lighter than a three-battery lead-acid bank.
2112W High Power Output for Heavy Loads
This battery doesn't just store more energy—it delivers it fast. With an industry-leading 165A BMS, it supports 2112W continuous output, enough to power heavy loads like air conditioners, microwaves, coffee makers, or even induction cooktops. That's more output than most 165Ah batteries in its class, which typically use only 120A to 150A BMS. One nice touch: if it trips due to overload, it auto-recovers in roughly 30 seconds.
One Battery Replaces Three 12V 100Ah Lead-Acid
At a 1C discharge rate, the Redodo 12V 165Ah battery offers the usable energy of three 12V 100Ah lead-acid batteries, but in a single, compact, and easy-to-install unit. No bulky, messy parallel wiring, just one battery, three times the performance. It also supports expandability of up to 4P4S, giving nearly 33.8 kWh if you stack multiple units.
Smart Bluetooth Monitoring
The built-in Bluetooth 5.0 module connects to the Redodo app, giving real-time insights into voltage, state of charge, charge/discharge current, temperature, and more. No more guestimating battery status at camp or on the water.
Premium EV-grade LFP Cells for Reliability
Redodo uses premium EV-grade prismatic cells, rated for 4,000 to 15,000 cycles—that's a decade or more of rugged use. The upgraded BMS safeguards against 20+ failure modes like overcharge, over-discharge, temperature extremes, salt spray, and humidity.
Real-World Feedback
Early adopters report strong results: an Arctic Fox camper owner used two units to run furnace, lights, and TV with no voltage sag; a sailor ran a 55 lbs trolling motor for three days and still had 80%+ charge left. Build quality, fast shipping, and solid customer support came up repeatedly in user reviews.
Get This Prime Day Deal at the Lowest Price
From July 8 to 11, during Redodo's Prime Day Sale, the 12V 165Ah Bluetooth Lithium Battery is available for just $309, saving a big $100 off. That's the lowest price ever for this compact Group 31 powerhouse!
With this exclusive deal, there's never been a better time to upgrade your power system and save big. Grab the deals on Redodo official store today and enjoy a 30-day price grarantee.
Score Big on Redodo Batteries This Prime Day 2025
Looking to more choice to upgrade your power system? Here are the best lithium battery deals from Redodo Prime Day Sale:
12V 100Ah LiFePO4 Battery – Now just $197 (was $219)
12V 100Ah Lithium Trolling Motor Battery – Now just $211 (was $229)
12V 140Ah Group 31 Bluetooth Battery – Now just $268 (was $299)
12V 300Ah Deep Cycle Lithium Battery – Now just $509 (was $549)
12V 100Ah Group 24 Deep Cycle Battery – Now just $207 (was $229)
12V 100Ah Group 24 & 31 Bluetooth Battery – Now just $225 (was $249)
12V 200Ah Deep Cycle LiFePO4 Battery – Now just $359 (was $409)
12V 410Ah Deep Cycle Lithium Battery – Now just $899 (was $1029)
12V 100Ah Group 27 Dual-Purpose Marine Battery – Now just $339 (was $379)
12V 140Ah Group 31 Dual-Purpose Marine Battery – Now just $424 (was $499)
24V 50Ah Bluetooth Trolling Motor Battery – Now just $237 (was $279)
24V 100Ah Lithium Deep Cycle Battery – Now just $379 (was $419)
36V 50Ah Trolling Motor Battery – Now just $314 (was $359)
48V 100Ah Bluetooth Solar/Golf Cart Battery – Now just $839 (was $899)
About Redodo
Redodo is an emerging lithium battery leading brand committed to delivering safe, reliable, and affordable LiFePO4 energy solutions for outdoor enthusiasts and off-grid users. With EV-grade LiFePO4 cells, advanced BMS technology, and high-quality customer service, Redodo empowers users to explore their adventures with confidence. Their mission is to awaken the passion for life and exploration by offering powerful, user-friendly energy solutions.
Media Contact
Company Name: Shenzhen Maicheng Technology Innovation Co., Ltd.
Contact Person: Yvonne, JO
Email: Send Email
Country: China
Website: www.redodopower.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
26 minutes ago
- Globe and Mail
Shareholder Alert: The Ademi Firm investigates whether BankFinancial Corporation is obtaining a Fair Price for its Public Shareholders
The Ademi Firm is investigating BankFinancial (Nasdaq: BFIN) for possible breaches of fiduciary duty and other violations of law in its transaction with First Financial Bancorp . Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ or toll-free: 866-264-3995. There is no cost or obligation to you. In the transaction, shareholders of BankFinancial will receive 0.48 shares of First Financial common stock in an all-stock transaction valued at approximately $142 million, based on First Financial's August 8 closing stock price. BankFinancial insiders will receive substantial benefits as part of change of control arrangements. The transaction agreement unreasonably limits competing transactions for BankFinancial by imposing a significant penalty if BankFinancial accepts a competing bid. We are investigating the conduct of the BankFinancial board of directors, and whether they are fulfilling their fiduciary duties to all shareholders. We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
Globe and Mail
26 minutes ago
- Globe and Mail
DDD LAWSUIT ALERT: Levi & Korsinsky Notifies 3D Systems Corporation Investors - Lead Plaintiff Deadline August 12, 2025
New York, New York--(Newsfile Corp. - August 11, 2025) - If you suffered a loss on your 3D Systems Corporation (NYSE: DDD) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: or contact Joseph E. Levi, Esq. via email at jlevi@ or call (212) 363-7500 to speak to our team of experienced shareholder advocates. Cannot view this video? Visit: THE LAWSUIT: A class action securities lawsuit was filed against 3D Systems Corporation that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between August 13, 2024 and May 12, 2025. CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) 3D Systems had understated the impact of weakened customer spending on the Company's business, while overstating its resilience in challenging industry conditions; (ii) in addition, the updated milestone criteria in the partnership with United Therapeutics Corporation would negatively impact the Company's regenerative medicine program revenue; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times. WHAT'S NEXT? If you suffered a loss in 3D Systems Corporation stock during the relevant time frame - even if you still hold your shares - go to to learn about your rights to seek a recovery. There is no cost or obligation to participate. WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.
Globe and Mail
26 minutes ago
- Globe and Mail
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on August 10, 2025, the Compensation Committee of its Board of Directors granted inducement equity grants to nine new employees, consisting of inducement restricted stock units, or RSUs, covering an aggregate of 45,100 shares of its common stock. These inducement RSUs are subject to the terms of Travere's 2018 Equity Incentive Plan ('2018 Plan') but were granted outside of the 2018 Plan and were granted as inducements material to the new employees entering into employment with Travere in accordance with Nasdaq Listing Rule 5635(c)(4). The RSUs vest over four years, with 25% of the shares vesting on each anniversary of the grant date, subject to the new employee's continued service relationship with Travere through the applicable vesting dates. About Travere Therapeutics At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit
